The repertoire of Fos and Jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 330-341

  Cook, Simon J ^a,b   Aziz, Natasha ^c   McMahon, Martin ^c  

^a ONYX PHARMACEUTICALS   (United States)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GENE PRODUCT; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL FATE; CELL TRANSFORMATION; DIMERIZATION; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; FIBROBLAST; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; TRANSACTIVATION;

EID: 0032931259     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.1.330     Document Type: Article

References (104)

1. Abate, C., D. Luk, and T. Curran. 1991. Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains. Mol. Cell. Biol. 11:3624-3632.
2. Agarwal, S., M. J. Corbley, and T. M. Roberts. 1995. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways. Oncogene 11:427-438.
3. Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
4. Alberts, A. S., O. Geneste, and R. Treisman. 1998. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell 92:475-487.
5. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
6. Angel, P., I. Baumann, B. Stein, H. Delius, H. J. Rahmsdorf, and P. Herrlich. 1987. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element in the 5′-flanking region. Mol. Cell. Biol. 7:2256-2266.
7. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
8. Aziz, N., H. Cherwinski, and M. McMahon. Unpublished data.
9. Balmanno, K., and S. J. Cook. Unpublished data.
10. Bergers, G., P. Graninger, S. Braselmann, C. Wrighton, and M. Busslinger. 1995. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15:3748-3758.
11. Brusselbach, S., U. Mohle-Steinlein, Z. Q. Wang, M. Schreiber, F. C. Lucibello, R. Muller, and E. F. Wagner. 1995. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene 10:79-86.
12. 2+ and protein kinase C in endothelin-stimulated Rat-1 cells. Biochem. J. 321:795-804.
13. Chen, R.-H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol. Cell. Biol. 12:915-927.
14. Chen, R.-H., P. C.-H. Juo, T. Curran, and J. Blenis. 1996. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12:1493-1502.
15. Cobb, M. H., J. E. Hepler, M. Cheng, and D. Robbins. 1994. The mitogen-activated protein kinases, ERK1 and ERK2. Semin. Cancer Biol. 5:261-268.
16. Coffer, P., M. de Jonge, A. Mettouchi, B. Binetruy, J. Ghysdael, and W. Kruijer. 1994. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Oncogene 9:911-921.
17. Cohen, D. R., and T. Curran. 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8:2063-2069.
18. Cohen, D. R., P. C. Ferreira, R. Gentz, B. R. Franza, Jr., and T. Curran. 1989. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev. 3:173-184.
19. Cook, S. J., B. Rubinfeld, I. Albert, and F. McCormick. 1993. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:3475-3485.
20. Cook, S. J., and F. McCormick. 1996. Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem. J. 320:237-245.
21. Cook, S. J., J. Beltman, K. A. Cadwallader, M. McMahon, and F. McCormick. 1997. Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells. J. Biol. Chem. 272:13309-13319.
22. Cook, S. J. Unpublished data.
23. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
24. Crews, C. M., A. Alessandrini, and R. L. Erickson. 1992. The primary structure of MEK, it protein kinase that phosphorylates the ERK gene product. Science 258:478-480.
25. Curran, T., A. D. Miller, L. Zokas, and I. M. Verma. 1984. Viral and cellular fos proteins: a comparative analysis. Cell 36:259-268.
26. Curran, T., and J. I. Morgan. 1987. Memories of fos. Bioessays 7:255-258.
27. De Cesare, D., D. Vallone, A. Caracciolo, P. Sassone-Corsi, C. Nerlov, and P. Verde. 1995. Heterodimerizalion of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11:365-376.
28. Dent, P., W. Haser, T. A. J. Haystead, L. A. Vincent, T. M. Roberts, and T. W. Sturgill. 1992. Activation of mitogen-activated protein kinase by v-Raf in NIH3T3 cells and in vitro. Science 257:1404-1407.
29. Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated hy UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
30. Devary, Y., R. A. Gottlieb, L. F. Lau, and M. Karin. 1991. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11:2804-2811.
31. Galang, C. K., C. J. Der, and C. A. Hauser. 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements including tandem c-Ets-2 binding sites. Oncogene 9:2913-2921.
32. Gentz, R., F. Rausher, C. Abate, and T. Curran. 1989. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science 243:1695-1699.
33. Ghosh, A., and M. E. Greenberg. 1995. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268:239-247.
34. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, and P. E. Shaw. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14:951-962.
35. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-438.
36. Gruda, M. C., K. Kovary, R. Metz, and R. Bravo. 1994. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9:2537-2547.
37. Hai, T., and T. Curran. 1991. Cross family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724.
38. Halazonetis, T. D., K. Georgeopoulos, M. E. Greenberg, and P. Leder. 1988. c-Jun dimerizes with itself and with c-Fos forming complexes with different binding affinities. Cell 55:917-924.
39. Hawker, K. L., J. K. Vass, and B. W. Ozanne. 1996. Isolation of novel, transcriptionally active AP-1 binding sites: implications for cellular transformation. Oncogene 13:283-292.
40. Heasley, L. E., and G. L. Johnson. 1992. The beta-PDGF receptor induces neuronal differentiation of PC12 cells. Mol. Biol. Cell 3:545-553.
41. Herber, B., M. Truss, M. Beato, and R. Müller. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295-3304.
42. Hill, C. S., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211.
43. Hipskind, R. A., M. Baccarini, and A. Nordheim. 1994. Transient activation of RAF-1, MEK, and ERK2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. Mol. Cell. Biol. 14:6219-6231.
44. Howe, L. R., S. J. Leevers, N. Gömez, S. Nakielny, P. Cohen, and C. J. Marshall. 1992. Activation of the MAP kinase pathway by the protein kinase raf. Cell 71:335-342.
45. Hu, E., E. Mueller, S. Oliviero, V. E. Papaioannou, R. Johnson, and B. M. Spiegelman. 1994. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13:3094-3103.
46. Johnson, C. M., C. S. Hill, S. Chawla, R. Treisman, and H. Bading. 1997. Calcium controls gene expression via three distinct pathways that can function independently of the Ras/mitogen-activated protein kinases (ERKs) signaling cascade. J. Neurosci. 17:6189-6202.
47. Johnson, G. L., and R. R. Vaillancourt. 1994. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6:230-238.
48. Johnson, R., B. Spiegelman, D. Hanahan, and R. Wisdom. 1996. Cellular transformation and malignancy induced by Ras require c-Jun. Mol. Cell. Biol. 16:4504-4511.
49. Kahan, C., K. Seuwen, S. Meloch, and J. Pouyssegur. 1992. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J. Biol. Chem. 267:13369-13375.
50. Karin, M., and T. Hunter. 1995. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5:747-757.
51. Kouzarides, T., and E. Ziff. 1989. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding. Nature 340:568-571.
52. 1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol. 12:5015-5023.
53. 1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11:2451-2459.
54. Kruijer, W., J. A. Cooper, T. Hunter, and I. M. Verma. 1984. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312:711-716.
55. Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature 358:417-421.
56. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160.
57. Lallemand, D., G. Spyrou, M. Yaniv, and C. M. Pfarr. 1997. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Oncogene 14:819-830.
58. Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759-1764.
59. Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608-20616.
60. Lee, W. M., C. Lin, and T. Curran. 1988. Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified Fos protein. Mol. Cell. Biol. 8:5521-5527.
61. Leevers, S. J., H. F. Paterson, and C. J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411-414.
62. Lenormand, P., C. Sardet, G. Pagés, G. L'Allemain, A. Brunet, and J. Pouysségur. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1079-1088.
63. Lloyd, A., N. Yancheva, and B. Wasylyk. 1991. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352:635-638.
64. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
65. Marais, R., Y. Light, H. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:101-110.
66. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
67. Marshall, C. J. 1996. Ras effectors. Curr. Opin. Cell Biol. 8:197-204.
68. May, G. H., M. Funk, E. J. Black, W. Clark, S. Hussain, J. R. Woodgett, and D. A. Gillespie. 1998. An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo. Curr. Biol. 8:117-120.
69. McCarthy, S. A., M. L. Samuels, C. A. Pritchard, J. A. Abraham, and M. McMahon. 1995. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9:1953-1964.
70. McCarthy, S. A., D. Chen, B. S. Yang, R. J. Garcia, H. Cherwinski, X. R. Chen, M. Klagsburg, C. A. Hauser, M. C. Ostrowski, and M. McMahon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401-2412.
71. Mechta, F., D. Lallemand, C. M. Pfarr, and M. Yaniv. 1997. Transformation by ras modifies AP1 composition and activity. Oncogene 14:837-847.
72. Miao, G. G., and T. Curran. 1994. Cell transformation by c-Fos requires an extended period of expression and is independent of the cell cycle. Mol. Cell. Biol. 14:4295-4310.
73. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723.
74. Morgan, J. I., and T. Curran. 1989. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 12:459-462.
75. Muller, R., R. Bravo, J. Burckhardt, and T. Curran. 1984. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312:716-720.
76. Murakami, M., M. H. Sonobe, M. Ui, Y. Kabuyama, H. Watanabe, T. Wada, H. Handa, and H. Iba. 1997. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Oncogene 14:2435-2444.
77. Musti, A. M., M. Treier, and D. Bohmann. 1997. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275:400-402.
78. Papavassiliou, A. G., M. Treier, and D. Bohmann. 1995. Intramolecular signal transduction in c-Jun. EMBO J. 14:2014-2019.
79. Rauscher, F. J., III, P. J. Voulalas, B. R. Franza, Jr., and T. Curran. 1988. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 2:1687-1699.
80. Robertson, L. M., T. K. Kerppola, M. Vendrell, D. Luk, R. J. Smeyne, C. Bocchiaro, J. I. Morgan, and T. Curran. 1995. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron 14:241-252.
81. Ryseck, R. P., and R. Bravo. 1991. c-Jun, JunB and JunD differ in their binding affinities to AP-1 and CRE consensus sequences; effect of Fos proteins. Oncogene 6:533-542.
82. Saez, E., S. E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, S. H. Yuspa, and B. M. Spiegelman. 1995. c-fos is required for malignant progression of skin tumors. Cell 82:721-732.
83. Samuels, M. L., M. J. Weber, M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252.
84. Cip1. Mol. Cell. Biol. 17:5588-5597.
85. Sonnenberg, J. L., P. F. Macgregor-Leon, T. Curran, and J. I. Morgan. 1989. Dynamic alterations in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 3:359-365.
86. Sonobe, M. H., T. Yoshida, M. Murakami, T. Kameda, and H. Iba. 1995. fra-2 promoter can respond to serum-stimulation through AP-1 complexes. Oncogene 10:689-696.
87. Stacey, D. W., T. Watson, H. F. Kung, and T. Curran. 1987. Microinjection of transforming Ras proteins induces c-fos expression. Mol. Cell. Biol. 7:523-527.
88. Stokoe, D., S. G. Macdonald, K. Cadwallader, M. Symons, and J. F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science 264:1463-1467.
89. Suzuki, T., M. Murakami, N. Onai, E. Fukuda, Y. Hashimoto, M. H. Sonobe, T. Kameda, M. Ichinose, K. Miki, and H. Iba. 1994. Analysis of AP-1 function in cellular transformation pathways. J. Virol. 68:3527-3535.
90. Traverse, S., P. Cohen, H. Paterson, C. Marshall, U. Rapp, and R. J. A. Grand. 1993. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. Oncogene 8:3175-3181.
91. Traverse, S., K. Seedorf, H. Paterson, C. J. Marshall, P. Cohen, and A. Ullrich. 1994. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4:694-701.
92. Treinies, I., H. F. Paterson, S. Hooper, R. Wilson, and C. J. Marshall. 1999. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell. Biol. 19:321-329.
93. Treisman, R. 1985. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell 42:889-902.
94. Treisman, R. 1994. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:96-101.
95. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
96. Vallone, D., S. Battista, G. M. Pierantoni, M. Fedele, L. Casalino, M. Santoro, G. Viglietto, A. Fusco, and P. Verde. 1997 Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J. 16:5310-5321.
97. van Aelst, L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213-6217.
98. Van Dam, H., D. Wilhelm, I. Herr, A. Steffen, P. Herrlich, and P. Angel. 1995. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:1798-1811.
99. Vouret-Craviari, V., E. Van Obberghen-Schilling, J. C. Scimeca, E. Van Obberghen, and J. Pouysségur. 1993. Differential activation of p44mapk (ERK1) by α-thrombin and thrombin-receptor peptide agonist. Biochem. J. 289:209-214.
100. Warne, P. H., P. R. Viciana, and J. Downward. 1993. Direct interaction of Ras and the amino terminal region of Raf-1 in vitro. Nature 364:352-355.
101. Whitmarsh, A. J., and R. S. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:589-607.
102. Wolthuis, R. M., N. D. de Ruiter, R. H. Cool, and J. L. Bos. 1997. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:6748-6761.
103. Cip1. Mol. Cell. Biol. 17: 5598-5611.
104. Yang, B. S., C. A. Hauser, G. Henkel, M. S. Colman, C. Van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538-547.